RT Journal Article
SR Electronic
T1 Influence of body mass index on SAPS3 prognostic performance in critically ill patients from Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.30.20086058
DO 10.1101/2020.04.30.20086058
A1 Ferreira, Isabella B. B.
A1 Menezes, Rodrigo C.
A1 Otero, Matheus L.
A1 Carmo, Thomas A.
A1 Telles, Gabriel P.
A1 Fahel, Bruno V. B.
A1 Barral-Netto, Manoel
A1 Arriaga, Maria B.
A1 Fukutani, Kiyoshi F.
A1 Neto, Licurgo Pamplona
A1 Agareno, Gabriel A.
A1 Agareno, Sydney
A1 Akrami, Kevan M.
A1 Filho, Nivaldo M.Filgueiras
A1 Andrade, Bruno B.
YR 2020
UL http://medrxiv.org/content/early/2020/05/05/2020.04.30.20086058.abstract
AB Obesity has emerged as a significant global health problem, and its association with increased morbidity and mortality is well established. An obesity paradox has been extensively documented in the critically ill, appearing as a protective factor. Whether body mass index (BMI) impacts critical care severity scores has not been extensively studied previously, particularly in developing countries. This study aimed to evaluate the performance of severity scores across different BMI categories in a tertiary intensive care unit in Brazil. Observational and analytical cohort study in a general ICU in Northeastern Brazil between August 2015 and July 2018 that included all patients over 18 years of age admitted to the ICU. A total of 2,179 patients were included, with a mean age of 67.9 years and female predominance (53.1%). Similar to previous findings, those with overweight and obesity of any grade were not significantly associated with mortality, though for each additional 1kg/m2 there was a decrease of 0.04% in odds of death. The Simplified Acute Physiology Score III (SAPS3) accurately predicted mortality in all groups except in those underweight. Low weight appeared as an independent risk factor for mortality in the ICU. Furthermore, this is the first study to identify poor prognostic performance of a common ICU severity score in those with low weight, highlighting the need for alternative more precise metrics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work of B.B.A. was supported by a grant from NIH (Rodrigo). I.B.B.F. was supported by UNEB: PICIN/UNEB. K.F.F. received a fellowship from the Programa Nacional de Pós-Doutorado, CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MBA was supported by a PhD fellowship from the Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used for analyses will be available after publication of the material upon request addressed to the corresponding author.